Keywords: |
mortality; drug efficacy; nonhuman; clinical trials as topic; note; animal; animals; bcg vaccine; interleukin 1beta; drug effect; bladder cancer; physiology; immune response; gamma interferon; vaccination; interleukin 6; cytokine production; immunological adjuvant; monocyte; staphylococcus aureus; adjuvants, immunologic; risk reduction; candida albicans; tuberculosis; virus pneumonia; tumor necrosis factor; clinical trial (topic); pandemic; procedures; childhood mortality; pneumonia, viral; yellow fever virus; humans; human; priority journal; coronavirus infections; heterologous immunity; betacoronavirus; coronavirus infection; pandemics; coronavirus disease 2019
|